Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/CSTONE-PHARMACEUTICALS-57946082/news/CStone-Pharmaceuticals-Announces-NMPA-Approval-of-Sugemalimab-as-First-Line-Treatment-for-Esophageal-45527856/?utm_source=whatsapp&utm_medium=social&utm_campaign=share